Zimbalwa iihomoni eziye zasuka kwiincwadi zefiziyoloji ezingacacanga zaya kwincoko eqhelekileyo ngokukhawuleza njenge-glucagon-like peptide-1 (GLP-1). Iqhutywa kakhulu kukuthandwa kwee-agonists ze-GLP-1 receptor agonists zamayeza, umdla wabathengi kwi-"GLP-1 support" uye wanda ngokukhawuleza waya kwindawo yokutya, iziselo, kunye nezongezelelo.
Yintoni i-GLP-1?
I-GLP-1 yi-peptide hormone ekhutshwa zii-L-cells kwi-intestinal lining ngenxa yokutya okunezakhamzimba, ingakumbi emva kokutya okuqulethe iiproteni, amafutha kunye nefayibha. Ikwiqela lee-hormone ezaziwa ngokuba zii-incretins, ezilungelelanisa ukugaya kunye nokubonisa i-metabolic. Nje ukuba ikhutshwe, i-GLP-1 isebenza kwii-receptors ezisasazwe kwi-pancreas, isibindi, ingqondo, amathumbu kunye nezicubu zamafutha, inika impembelelo kwiinkqubo ezininzi ezidibeneyo endaweni yendlela enye (Lotosky et al., 2025).
Kwipancreas, i-GLP-1 inyusa ukukhutshwa kwe-insulin kwaye ixhasa ukusebenza kweeseli ze-beta. Engqondweni, isebenzisana namaziko okutya ukuze ikhuthaze ukuhlutha nokunciphisa indlela yokufuna ukutya. Emathunjini, inciphisa ukuphelelwa yisisu, nto leyo eyandisa imvakalelo yokugcwala emva kokutya. Izenzo zayo kwimisipha yesibindi kunye nethambo, kubandakanya inkxaso yokwenziwa kwe-glycogen kunye nokusetyenziswa kwamandla, zisabonakala kodwa zithathwa njengezibalulekileyo kwimiphumo yayo ebanzi ye-metabolic (Lotosky et al., 2025).
Funda kwakhona: Iingenelo zeMilk Thistle kwiSibindi nakwiShukela yegazi
Ngenxa yokuba i-GLP-1 yaphulwe ngokukhawuleza emzimbeni yi-enzyme dipeptidyl peptidase-4 (DPP-4), isithuba sayo sendalo sokubonisa iimpawu sifutshane. Le yenye yezizathu zokuba ii-agonists ze-GLP-1 receptor agonists zenziwe ngezakhiwo eziguquliweyo ezichasene nokubola kwe-DPP-4 (Lotosky et al., 2025).
Kukwangunobangela wokuba abaphandi bezondlo babe nomdla kwizithako ezinokuxhasa umsebenzi we-GLP-1 womzimba, nokuba kukukhuthaza ukukhululwa kwayo okanye kuthintele i-enzyme eyiqhekezayo.
Indima ye-GLP-1 kuLawulo lokuTya ukutya
Umnqweno wokutya awulawulwa luphawu olunye kodwa luthungelwano lonxibelelwano lwamathumbu nobuchopho, apho i-GLP-1 idlala indima yokulungelelanisa. Emva kokutya, amanqanaba aphezulu e-GLP-1 anegalelo ekunciphiseni indlala, ukukhupha isisu kancinci, kunye nokwanda kweemvakalelo zokugcwala. Olu dibaniso lunceda ukuchaza isizathu sokuba i-GLP-1 ibe yeyona nto iphambili kuphando lokulawula ubunzima, zombini amayeza kunye nezondlo. Okubalulekileyo, i-GLP-1 ayisebenzi yodwa; isebenzisana nezinye iihomoni zamathumbu, kubandakanya i-ghrelin kunye ne-peptide YY, njengenxalenye yenkqubo ebanzi yokulawula inkanuko.
Umsebenzi we-GLP-1 kunye neMetabolic
Ngaphaya kokutya, ukuhanjiswa kwe-GLP-1 okunxulumene nomqondiso kuye kwanxulunyaniswa nokulawulwa kweglucose, imetabolism ye-lipid, kunye nokusetyenziswa kwamandla. Kwizicubu zesibindi, i-GLP-1 ixhasa ukwenziwa kwe-glycogen ngeendlela ezixhomekeke kwi-insulin kunye neendlela ezinokubakho zokuxhomekeka kwi-insulin. Kwizicubu ze-adipose, i-GLP-1 ibikwe ukuba ikhuthaza i-brown adipose tissue thermogenesis kunye nokusetyenziswa kwamandla, indlela ethathwa njengefanelekileyo ekulahlekeni kobunzima enxulunyaniswa nonyango lwe-GLP-1 receptor agonist (Lotosky et al., 2025).
Ezi ndlela zisaqhubeka nokuba yindawo esebenzayo yophando, kwaye kukho izikhewu ezibalulekileyo zolwazi ezivunyiweyo kwiincwadi, ingakumbi malunga nobungakanani bemiphumo ethe ngqo ye-GLP-1 kwizicubu ezithile.
Funda kwakhona: Izongezo zeLiposomal: Ixesha elitsha lokufunxwa kwezondlo
Iindlela zeZityalo zokuxhasa iindlela ze-GLP-1
Uphando olukhulayo lwezondlo luye lwahlola ukuba ingaba izicatshulwa ezithile ezivela kwizityalo zinokuchaphazela umsebenzi we-GLP-1 wangaphakathi, nokuba kukuvuselela ukukhutshwa kwayo emathunjini okanye ngokulawula umsebenzi we-DPP-4, i-enzyme ebangela ukuqhekeka ngokukhawuleza kwe-GLP-1. Umdla kule ndawo uye wanda kunye nengxoxo ebanzi ye-GLP-1, apho abenzi be-formulators bejonge ngakumbi kwiindlela ezisekelwe kwisondlo ezisebenza ngendlela efanayo ne-incretin njengonyango lwe-GLP-1 lwamayeza, ngaphandle kokuba ziimveliso zamayeza ngokwazo.
Umzekelo omnye ovela kwipotifoliyo yeNaturMed Scientific yiTheolim, indibaniselwano esemgangathweni, enelungelo lobunikazi ye-Key lime (Citrus aurantifolia) i-rind kunye ne-cocoa (Theobroma cacao) seed extracts. Kwinkqubo ehleliweyo yophando lwangaphambi kweklinikhi kunye nolweklinikhi, iTheolim ihlolwe ngemiphumo yayo kwinkcitho yamandla, ukwakheka komzimba, kunye neempawu ezinxulumene ne-metabolic. Kwiimodeli zeseli kunye nezilwanyana, indibaniselwano ibonwe ukuxhasa ukubonakaliswa kweeproteni ezinxulumene nomsebenzi we-thermogenic, kubandakanya ukukhupha iproteni-1 kunye ne-beta-3 adrenergic receptor, ukuya kwinqanaba eliphezulu kune-source extract yodwa (Kundimi et al., 2024).
Uphando lwabantu luye lwaqhubeka ukususela kuvavanyo olukhawulezileyo lwe-crossover, apho izinga lokuphumla kwe-metabolic kunye ne-oxidation yamafutha zaziphezulu kakhulu emva kwedosi enye xa kuthelekiswa ne-placebo (Ammatalli et al., 2024), ukuya kuvavanyo lweeveki ezili-16 olucwangcisiweyo, olungaboni kabini, olulawulwa yi-placebo kubantu abadala abali-120 abatyebe kakhulu.
Funda kwakhona: Izithako ezinophawu
Kolo vavanyo lweeveki ezili-16, ukongezwa kweTheolim kwanxulunyaniswa nokwehla okukhulu kobunzima bomzimba kunye nobunzima bamafutha xa kuthelekiswa ne-placebo, kunye nokunyuka okuphakathi kwe-33% kwi-serum GLP-1 ukusuka kwisiseko kwiveki ye-16, ukwehla okukhulu kwi-ghrelin, kunye nokuphuculwa kweempawu ezikhethiweyo ze-lipid kunye ne-insulin-sensitivity (Chadalavada et al., 2025). Oku kusengomnye weengcezu ezibalulekileyo zobungqina babantu ukuza kuthi ga ngoku ezidibanisa indibaniselwano yezityalo esekwe kukutya nomsebenzi we-GLP-1 wendalo, nangona ukuphindaphinda ngokuzimeleyo kunye nokuchazwa ngakumbi kotshintsho lwe-biomarker kuya kuqinisa isiseko sobungqina.
Umxholo kunye nemida
Nangona le ndawo yophando isanda ngokukhawuleza, kukho izinto ezininzi ekufuneka ziqwalaselwe. Ubungqina obuninzi bobuchwephesha obudibanisa izithako zezityalo nomsebenzi we-GLP-1 buqala kwiimodeli zeseli nezilwanyana, ezingenako ukutolikwa ngokuthe ngqo kwiziphumo zabantu kwaye ziqondwa ngcono njengezokuqala. Uphando lwe-GLP-1 lwezityalo alwandisi uluhlu lwamabango avumelekileyo olwakhiwo-umsebenzi wezongezo zokutya kwiindawo ezininzi zolawulo; nangona kunjalo, lunokuqinisa ingqiqo yesayensi esisiseko yamabango akhoyo malunga nokwanela, ukulawulwa kokutya, kunye nempilo ye-metabolic. Abenzi beefom kunye neebhrendi bayakhuthazwa ukuba babeke uphando lwezityalo olunxulumene ne-GLP-1 njengenxalenye yebali elibanzi lempilo ye-metabolic, endaweni yokuba lube yindawo ethe ngqo yesondlo yonyango lwe-GLP-1 olumiselweyo.
Qaphela: Izithako kunye nezifundo ekuxoxwe ngazo kweli nqaku zizithako zezongezo zokutya, azizo iimveliso zamayeza ezinelayisenisi, kwaye azijoliswanga ekuxilongeni, ekunyangeni, ekunyangeni, okanye ekuthinteleni nasiphi na isifo. Abathengi abaneengxaki zempilo esele zikhona okanye abo basebenzisa amayeza, kuquka amayeza e-GLP-1 receptor agonist, bayacetyiswa ukuba badibane neengcali zempilo ezifanelekileyo ngaphambi kokuba basebenzise.
Ucaphulo
U-Ammatalli, NKR, uKuricheti, i-SSSK, uVeeramachaneni, S., uKoo, uYK, uRamanathan, G. kunye noYalamanchi, A. (2024) 'Umxube we-Citrus aurantifolia fruit rind kunye ne-Theobroma cacao seed extracts supplementation kuphucula amazinga e-metabolic kubantu abatyebe kakhulu: uphando olucwangcisiweyo, olulawulwa yi-placebo, oluhambahambayo', uPhando lwezoKutya kunye neZondlo, 68, inqaku 10745. Ifumaneka apha: https://doi.org/10.29219/fnr.v68.10745
UChadalavada, A., Koo, YK, Kim, S., Veeramachaneni, S., Ramanathan, G. kunye noYalamanchi, A. (2025) 'Umxube wezityalo osebenzisa i-thermogenic oqulethe i-Citrus aurantifolia fruit rind kunye ne-Theobroma cacao seed extracts uphucula ukwakheka komzimba kubantu abadala abatyebileyo: uphando lweklinikhi', uPhando lwezoKutya kunye neZondlo, 69, inqaku 12159. Ifumaneka apha: https://doi.org/10.29219/fnr.v69.12159
Kundimi, S., Chinta, G., Alluri, KV, Golakoti, T., Veeramachaneni, S., Ramanathan, G. kunye noSengupta, K. (2024) 'Umxube wezityalo ohambelanayo unyusa iindleko zamandla okuphumla kwaye unciphisa ukutyeba kwiimpuku ezityelwe ukutya okunamafutha amaninzi', Ijenali ye-American Nutrition Association, 43(3), iphe. 286–295. Ifumaneka apha: https://doi.org/10.1080/27697061.2023.2280777
ULotosky, J., uJean, X., uAltankhuyag, A., uKhan, S., uBernotas, A., uSharafshah, A., uBlum, K., uPosner, A. kunye noThanos, PK (2025) 'I-GLP-1 kunye nendima yayo kwimveliso ye-glycogen: uphononongo olubalisayo', iBiomedicines, 13(7), inqaku 1610. Ifumaneka apha: https://doi.org/10.3390/biomedicines13071610
Isikhanyeli: Le ngxelo ayikhange ihlolwe yi-EFSA, i-KFDA okanye i-FDA. Le mveliso ayenzelwanga ukuxilonga, ukunyanga, ukunyanga, okanye ukuthintela nasiphi na isifo. Nangona ulwazi olunikiweyo lusekelwe kwiingxelo ezithembekileyo, asenzi naziphi na izibango okanye iziqinisekiso ezithile. Kubalulekile ukubonisana nomcebisi wakho wezempilo ukuze ufumane iingcebiso kunye nesikhokelo esihambelana nempilo yakho.
